Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

5.05
-0.2000-3.81%
Post-market: 5.050.00000.00%19:37 EDT
Volume:1.77M
Turnover:9.21M
Market Cap:1.71B
PE:-8.30
High:5.39
Open:5.24
Low:5.02
Close:5.25
52wk High:9.25
52wk Low:2.94
Shares:338.22M
Float Shares:122.00M
Volume Ratio:1.10
T/O Rate:1.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6081
EPS(LYR):0.0964
ROE:--
ROA:2.19%
PB:-8.92
PE(LYR):52.41

Loading ...

Alvotech's Q4 Approval, Launch Timelines Remain Intact, UBS Says

MT Newswires Live
·
Yesterday

Alvotech Sa : Bofa Global Research Initiates Coverage with Buy Rating; Price Objective $7

THOMSON REUTERS
·
Aug 24

BofA Securities Initiates Alvotech at Buy With $7 Price Target

MT Newswires Live
·
Aug 24

Lotus Pharma Unit to License Two Alvotech Biosimilars in $150 Million Deal

MT Newswires Live
·
Aug 24

Alvotech Strikes $150 Million Biosimilar Deal With Lotus for U.S. and Key Asian Markets

TIPRANKS
·
Aug 21

Alvotech Signs Licensing, Commercialization Deal with Lotus Pharma for Imfinzi, Hemlibra Biosimilars in US, Asia

Reuters
·
Aug 21

Alvotech - Announces Strategic Licensing and Commercialization Agreement with Lotus Pharmaceutical

THOMSON REUTERS
·
Aug 21

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for Proposed Biosimilars to Durvalumab and Emicizumab in the U.S. and Selected Asian Markets

THOMSON REUTERS
·
Aug 21

Alvotech - Retains Right to Commercialize Avt34 and Avt87 Directly in U.S.

THOMSON REUTERS
·
Aug 21

Alvotech - Lotus Granted Exclusive Rights for Avt34 and Avt87 in Eight Asian Markets

THOMSON REUTERS
·
Aug 21

Alvotech - Agreement Has Potential Value of up to $150 Mln in Upfront and Milestone Payments

THOMSON REUTERS
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program

Reuters
·
Aug 20

Alvotech Files H1 2026 Results and Schedules Business Update Call

TIPRANKS
·
Aug 20

Alvotech Posts H1 Net Loss as Manufacturing, Quality Upgrades Curb Product Revenue, Company Says

Reuters
·
Aug 20

Alvotech Q2 EPS $(0.17) Misses $(0.04) Estimate, Sales $106.000M Miss $111.010M Estimate

Benzinga Earnings
·
Aug 20

Alvotech Sa: Management Anticipates Total Revenues to be in Range of $650-$700 Mln and Adjusted Ebitda to be in Range of $180-220 Mln in 2026

THOMSON REUTERS
·
Aug 20

Alvotech H1 Product Revenue USD 211.9 Million

THOMSON REUTERS
·
Aug 20

Press Release: Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Dow Jones
·
Aug 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 19